Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Shareholders' Equity

v3.10.0.1
Consolidated Statement of Shareholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit
Common Stock, Shares, Outstanding period beginning at Jan. 28, 2017   65,192,314    
Total Shareholders' Equity period beginning at Jan. 28, 2017 $ 81,703,000 $ 652,000 $ 436,962,000 $ (355,911,000)
Net loss (6,290,000) $ 0 0 (6,290,000)
Repurchases of common stock, Shares   (4,400,000)    
Repurchases of common stock, Value (5,055,000) $ (44,000) (5,011,000) 0
Common stock issuances pursuant to equity compensation plans, Shares   360,644    
Common stock issuances pursuant to equity compensation plans, Value 11,000 $ 4,000 7,000 0
Share-based payment compensation, Shares   0    
Share-based payment compensation, Value 2,057,000 $ 0 2,057,000 0
Common stock and warrant issuance, Shares   4,108,273    
Common stock and warrant issuance, Value 4,283,000 $ 41,000 4,242,000 0
Common Stock, Shares, Outstanding period end at Oct. 28, 2017   65,261,231    
Total Shareholders' Equity period end at Oct. 28, 2017 76,709,000 $ 653,000 438,257,000 (362,201,000)
Common Stock, Shares, Outstanding period beginning at Jul. 29, 2017   65,220,233    
Total Shareholders' Equity period beginning at Jul. 29, 2017 77,003,000 $ 652,000 437,449,000 (361,098,000)
Net loss (1,103,000) $ 0 0 (1,103,000)
Common stock issuances pursuant to equity compensation plans, Shares   40,998    
Common stock issuances pursuant to equity compensation plans, Value 19,000 $ 1,000 18,000 0
Share-based payment compensation, Shares   0    
Share-based payment compensation, Value 790,000 $ 0 790,000 0
Common Stock, Shares, Outstanding period end at Oct. 28, 2017   65,261,231    
Total Shareholders' Equity period end at Oct. 28, 2017 $ 76,709,000 $ 653,000 438,257,000 (362,201,000)
Common Stock, Shares, Outstanding period beginning at Feb. 03, 2018 65,290,458 65,290,458.000    
Total Shareholders' Equity period beginning at Feb. 03, 2018 $ 83,996,000 $ 653,000 439,111,000 (355,768,000)
Net loss (12,183,000) $ 0 0 (12,183,000)
Common stock issuances pursuant to equity compensation plans, Shares   1,073,387    
Common stock issuances pursuant to equity compensation plans, Value 51,000 $ 11,000 40,000 0
Share-based payment compensation, Shares   0    
Share-based payment compensation, Value $ 2,206,000 $ 0 2,206,000 0
Common Stock, Shares, Outstanding period end at Nov. 03, 2018 66,363,845 66,363,845.000    
Total Shareholders' Equity period end at Nov. 03, 2018 $ 74,070,000 $ 664,000 441,357,000 (367,951,000)
Common Stock, Shares, Outstanding period beginning at Aug. 04, 2018   66,287,786    
Total Shareholders' Equity period beginning at Aug. 04, 2018 82,338,000 $ 663,000 440,469,000 (358,794,000)
Net loss (9,157,000) $ 0 0 (9,157,000)
Common stock issuances pursuant to equity compensation plans, Shares   76,059    
Common stock issuances pursuant to equity compensation plans, Value 67,000 $ 1,000 66,000 0
Share-based payment compensation, Shares   0    
Share-based payment compensation, Value $ 822,000 $ 0 822,000 0
Common Stock, Shares, Outstanding period end at Nov. 03, 2018 66,363,845 66,363,845.000    
Total Shareholders' Equity period end at Nov. 03, 2018 $ 74,070,000 $ 664,000 $ 441,357,000 $ (367,951,000)